CLINICAL-PHARMACOLOGY OF SULFONYLUREAS

被引:40
作者
MELANDER, A
机构
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1987年 / 36卷 / 02期
关键词
D O I
10.1016/0026-0495(87)90195-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:12 / 16
页数:5
相关论文
共 26 条
[1]   INFLUENCE OF SULFONYLUREAS ON THE SECRETION, DISPOSAL AND EFFECT OF INSULIN [J].
ALMER, LO ;
JOHANSSON, E ;
MELANDER, A ;
WAHLINBOLL, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (01) :27-32
[2]  
ASPLUND K, 1983, DIABETOLOGIA, V24, P412
[3]  
BITZEN PO, 1984, ACTA ENDOCRINOL-COP, V105, P37
[4]  
BITZEN PO, UNPUB DIABETES CARE
[5]  
EFENDIC S, 1981, SKANDIA INT S STOCKH, P75
[6]   A NEW ANTI-DIABETIC PRINCIPLE [J].
FRANKE, H ;
FUCHS, J .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1955, 80 (40) :1449-1452
[7]  
FULLER JH, 1980, LANCET, V1, P1373
[8]  
GROOP PH, IN PRESS COMP PHARMA
[9]   CLINICAL-PHARMACOLOGY OF SULFONYLUREA HYPOGLYCEMIC AGENTS .2. [J].
JACKSON, JE ;
BRESSLER, R .
DRUGS, 1981, 22 (04) :295-320
[10]  
JANBON B, 1942, MONTPELLIER MED, V21, P441